| 47th week of 2018 patent applcation highlights part 7 |
| Patent application number | Title | Published |
|---|
| 20180333359 | NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION | 2018-11-22 |
| 20180333360 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING PAIN | 2018-11-22 |
| 20180333361 | ALKYL CELLULOSE FOR USE IN TABLETING AND SOLID PREPARATION COMPRISING SAME | 2018-11-22 |
| 20180333362 | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems | 2018-11-22 |
| 20180333363 | FAST DISSOLVING TABLET FORMULATIONS AND METHODS OF MAKING THEREOF | 2018-11-22 |
| 20180333364 | RALOXIFENE SPRINKLE COMPOSITION | 2018-11-22 |
| 20180333365 | MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF HUPERZINE AND METHODS OF USING THE SAME | 2018-11-22 |
| 20180333366 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS | 2018-11-22 |
| 20180333367 | Patches and Methods for the Transdermal Delivery of a Therapeutically Effective Amount of Iron | 2018-11-22 |
| 20180333368 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING ARTHRITIS | 2018-11-22 |
| 20180333369 | DEVICE AND METHOD FOR THE TRANSDERMAL DELIVERY OF CANNABIDIOL | 2018-11-22 |
| 20180333370 | CANNABIDIOL FOR TREATMENT OF SEVERE AND REFRACTORY GRAFT-VERSUS-HOST DISEASE | 2018-11-22 |
| 20180333371 | CURCUMIN AND RESVERATROL FOR CHRONIC INFLAMMATION | 2018-11-22 |
| 20180333372 | COMPOSITION, USE THEREOF, AND METHODS OF MANUFACTURING | 2018-11-22 |
| 20180333373 | TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE | 2018-11-22 |
| 20180333374 | MORE POTENT AND LESS TOXIC FORMULATIONS OF EPINEPHRINE AND METHODS OF MEDICAL USE | 2018-11-22 |
| 20180333375 | COMPOUND FOR TREATING OPEN INJURY, AND PREPARATION METHOD AND APPLICATION THEREOF | 2018-11-22 |
| 20180333376 | USE OF (BENZENESULFONAMIDO) BENZAMIDE COMPOUNDS FOR INHIBITING LIVER FIBROSIS | 2018-11-22 |
| 20180333377 | METHODS AND COMPOSITIONS FOR TREATING RAYNAUD'S DISEASE | 2018-11-22 |
| 20180333378 | USE OF GC-1 IN TRANSPLANT RELATED POPULATION | 2018-11-22 |
| 20180333379 | CITRATE DISSOLUTION OF BETA-2-MICROGLOBULIN AND AMYLOID BETA PEPTIDE (1-40) AGGREGATES | 2018-11-22 |
| 20180333380 | USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER | 2018-11-22 |
| 20180333381 | MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF | 2018-11-22 |
| 20180333382 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME | 2018-11-22 |
| 20180333383 | Compositions and Methods for Lowering Triglycerides in a Subject Having Reduced Kidney Function | 2018-11-22 |
| 20180333384 | ANTIBACTERIAL MICROELEMENT CHELATES AND THE USE THEREOF IN ANIMAL FEEDS | 2018-11-22 |
| 20180333385 | METHODS FOR TREATING CANCER | 2018-11-22 |
| 20180333386 | AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES | 2018-11-22 |
| 20180333387 | PRODUCT COMPRISING RED CLOVER EXTRACT AND METHODS FOR PRODUCING THE SAME | 2018-11-22 |
| 20180333388 | COMPOSITION AND MEDICAL PRODUCT FOR REDUCING BODY WEIGHT AND BODY FAT, AND USE OF SAID PRODUCT | 2018-11-22 |
| 20180333389 | VITAMIN E COMPOSITIONS AND METHODS OF USE THEREFOR | 2018-11-22 |
| 20180333390 | COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT | 2018-11-22 |
| 20180333391 | SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS | 2018-11-22 |
| 20180333392 | COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM | 2018-11-22 |
| 20180333393 | Delayed Release Feed-Through Veterinary Compositions With Ovicidal And Larvicidal Activity Against Susceptible And Resistant Strains Of Parasites In Ruminants' Feces, Use Of These Compositions, Method For Delaying The Release Of These Compositions | 2018-11-22 |
| 20180333394 | COMPOSITIONS AND METHODS EMPLOYING WOLBACHIA FTSZ AS A TARGET FOR ALBENDAZOLE SULFONE | 2018-11-22 |
| 20180333395 | CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | 2018-11-22 |
| 20180333396 | PPAR COMPOUNDS FOR USE IN THE TREATMENT OF FIBROTIC DISEASES | 2018-11-22 |
| 20180333397 | METHODS FOR TREATING EPILEPSY | 2018-11-22 |
| 20180333398 | METHOD OF WEIGHT REDUCTION | 2018-11-22 |
| 20180333399 | METHOD OF IMPROVING LIVER FUNCTION | 2018-11-22 |
| 20180333400 | B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS | 2018-11-22 |
| 20180333401 | METHODS OF TREATING LIVER DISEASE | 2018-11-22 |
| 20180333402 | PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF | 2018-11-22 |
| 20180333403 | ORGANIC COMPOUNDS | 2018-11-22 |
| 20180333404 | Pharmaceutical composition for prevention or treatment of diabetes or fatty liver comprising CYP4A inhibitor | 2018-11-22 |
| 20180333405 | COMBINATION THERAPY | 2018-11-22 |
| 20180333406 | BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF | 2018-11-22 |
| 20180333407 | Methods Of Safely Transitioning A Subject To Buprenorphine | 2018-11-22 |
| 20180333408 | 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT | 2018-11-22 |
| 20180333409 | METHOD OF TREATING A PATIENT WITH A CYP3A4 SUBSTRATE DRUG | 2018-11-22 |
| 20180333410 | METHOD OF TREATING A PATIENT WITH A CYP3A4 SUBSTRATE DRUG | 2018-11-22 |
| 20180333411 | METHODS OF TREATMENT | 2018-11-22 |
| 20180333412 | METHODS FOR TREATING NEUROBLASTOMA | 2018-11-22 |
| 20180333413 | PHARMACEUTICAL COMPOSITION CONTAINING 2-{4-[N-(5,6-DIPHENYLPYRAZIN-2-YL)-N-ISOPROPYLAMINO]BUTYLOXY}-N-(METHYLSU- LFONYL)ACETAMIDE | 2018-11-22 |
| 20180333414 | OPHTHALMIC COMPOSITIONS AND METHODS OF USE | 2018-11-22 |
| 20180333415 | THERAPEUTIC METHODS | 2018-11-22 |
| 20180333416 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF | 2018-11-22 |
| 20180333417 | SUBSTITUTED XANTHINE DERIVATIVES | 2018-11-22 |
| 20180333418 | USE OF PAN FGFR INHIBITORS AND METHOD OF IDENTIFYING PATIENTS WITH CANCER ELIGIBLE FOR TREATMENT WITH A PAN FGFR INHIBITOR | 2018-11-22 |
| 20180333419 | METHOD FOR PROCESSING A LIQUID MEDIUM COMPRISING CELLS | 2018-11-22 |
| 20180333420 | PHARMACEUTICAL COMPOSITIONS FOR TREATING PAIN | 2018-11-22 |
| 20180333421 | METHODS OF TREATING ORAL MUCOSITIS | 2018-11-22 |
| 20180333422 | ORAL TESTOSTERONE UNDECANOATE THERAPY | 2018-11-22 |
| 20180333423 | METHODS OF TREATING TESTOSTERONE DEFICIENCY | 2018-11-22 |
| 20180333424 | OXYSTEROL-STATIN COMPOUNDS FOR BONE GROWTH | 2018-11-22 |
| 20180333425 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY | 2018-11-22 |
| 20180333426 | NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF | 2018-11-22 |
| 20180333427 | ANTI-FATIGUE COMPOSITION AND USE THEREOF | 2018-11-22 |
| 20180333428 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GUT PERMEABILITY-RELATED DISORDERS | 2018-11-22 |
| 20180333429 | FASTING FORMULATION | 2018-11-22 |
| 20180333430 | CORE-SHELL CROSSLINKED HYALURONIC ACID GEL PARTICLES, PRODUCTION METHOD FOR SAME, AND MEDICAL MATERIAL | 2018-11-22 |
| 20180333431 | SUSTAINED-RELEASE COMPOSITION, METHOD FOR FABRICATING, AND USE THEREOF | 2018-11-22 |
| 20180333432 | METHODS AND MATERIALS FOR TREATING CANCER | 2018-11-22 |
| 20180333433 | SYNTHESIS OF SILVER NANOPARTICLES USING SESAME OIL CAKE | 2018-11-22 |
| 20180333434 | USE OF COMMON GAMMA CHAIN CYTOKINES FOR THE VISUALIZATION, ISOLATION AND GENETIC MODIFICATION OF MEMORY T LYMPHOCYTES | 2018-11-22 |
| 20180333435 | BK VIRUS SPECIFIC T CELLS | 2018-11-22 |
| 20180333436 | ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE USING ROR1-POSITIVE MESENCHYMAL STEM CELLS | 2018-11-22 |
| 20180333437 | PHARMACEUTICAL COMPOSITION INCLUDING IL-10-EXPRESSING NEURAL STEM CELLS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASE OR INJURY AND TREATMENT METHOD USING THE SAME | 2018-11-22 |
| 20180333438 | CELL-BASED THERAPY FOR THE PULMONARY SYSTEM | 2018-11-22 |
| 20180333439 | ATTENUATED OR INACTIVATED PATHOGENIC ESCHERICHIA COLI FOR TREATING UROGENITAL CANCER | 2018-11-22 |
| 20180333440 | BACTERIAL COMPOSITIONS AND METHODS OF USE THEREOF | 2018-11-22 |
| 20180333441 | COMPOSITION FOR ALCOHOL OR ACETALDEHYDE DEGRADATION COMPRISING PROBIOTICS | 2018-11-22 |
| 20180333442 | PROBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF | 2018-11-22 |
| 20180333443 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING FOWL PRODUCTION | 2018-11-22 |
| 20180333444 | BACTERIOPHAGE COMPOSITIONS AND METHODS OF USE THEREOF | 2018-11-22 |
| 20180333445 | METHOD FOR PREPARING FRESH CHLORELLA DRINK AND USE OF THE FRESH CHLORELLA DRINK | 2018-11-22 |
| 20180333446 | CBX EXTRACTION-ISOLATION PROCESS | 2018-11-22 |
| 20180333447 | BENEFICIAL EFFECTS OF BIDENS PILOSA ON GUT MICROFLORA AND ANIMAL HEALTH | 2018-11-22 |
| 20180333448 | METHOD FOR PREPARING FENUGREEK EXTRACT, PHARMACEUTICAL COMPOSITION COMPRISING FENUGREEK EXTRACT, AND USE THEREOF | 2018-11-22 |
| 20180333449 | HERBO-MINERAL FORMULATION FOR THE TREATMENT OF CARDIO VASCULAR DISEASES AND METHOD OF PREPARATION THEREOF | 2018-11-22 |
| 20180333450 | COMPOSITIONS AND METHODS FOR MITIGATING METHANOGENESIS IN ANIMALS | 2018-11-22 |
| 20180333451 | B-1A LYMPHOCYTE AND/OR MACROPHAGE TARGETING AND ACTIVATION TO TREAT MEDICAL CONDITIONS WITH INFLAMMATORY OR AUTOIMMUNE COMPONENTS | 2018-11-22 |
| 20180333452 | ENDOPLASMIC RETICULUM STRESS AS A PREDICTIVE TOOL IN CANCER THERAPY AND A COMBINATION THERAPY FOR THE TREATMENT OF CANCER | 2018-11-22 |
| 20180333453 | VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION | 2018-11-22 |
| 20180333454 | VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION | 2018-11-22 |
| 20180333455 | A METHOD FOR MODULATING INSULIN-INDEPENDENT GLUCOSE TRANSPORT USING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE (TCAP) | 2018-11-22 |
| 20180333456 | OPTICALLY-CONTROLLED CNS DYSFUNCTION | 2018-11-22 |
| 20180333457 | TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR | 2018-11-22 |
| 20180333458 | MESENCHYMAL STEM CELLS FOR THE TREATMENT OF CNS DISEASES | 2018-11-22 |
